• CSBTA Pharmacokinetics in MASH: Key Study Insights

  2026-08-20

  The reference study integrates plasma pharmacokinetics, tissue distribution, cellular transport, microsomal metabolism, and regulatory protein expression to explain why Corydalis saxicola Bunting total alkaloids behave differently in HFHCD-induced MASH mice. Its findings show disease- and dose-dependent increases in systemic exposure and hepatic accumulation, providing a framework for more cautious dosing and pharmacokinetic interpretation in MASLD/MASH research.

• AZD2461: Rethinking PARP Inhibitor Response

  2026-08-20

  A translational perspective on AZD2461 as a novel PARP inhibitor, emphasizing DNA repair pathway modulation, response metrics, Pgp-associated resistance, and biomarker-aware study design in breast cancer research.

• PAD4-IN-2 TFA: Reliable Assay Design

  2026-08-19

  This scenario-based guide explains how PAD4-IN-2 TFA (SKU C8757) can improve interpretation of viability, proliferation, migration, H3cit, and NET assays. It connects reported biochemical and preclinical data with practical controls, dosing considerations, storage guidance, and vendor-selection criteria.

• Quantifying Fractional Killing by High-Throughput Microscopy

  2026-08-19

  Inde, Rodencal, and Dixon present a longitudinal high-throughput microscopy protocol for measuring the fraction of cells killed by anticancer treatments rather than relying only on population-average viability. The workflow combines fluorescent live-cell counting with dead-cell labeling to compare many treatment conditions and reveal variability in MEK1/2 inhibitor-induced killing.

• Multiplexed ACE2 Libraries Reveal SARS-CoV-2 Receptor Shifts

  2026-08-18

  Shukla and colleagues developed a barcoded pseudotyped-virus assay that measures how multiple ACE2 sequences support entry by SARS-CoV-2 spike variants in parallel. The study shows that variant spikes produce modest changes in human ACE2 usage but much larger, variant-specific shifts across animal ACE2 orthologs, clarifying how viral evolution can alter cross-species compatibility.

• BIBP 3226: NPY/NPFF Research Tool

  2026-08-18

  BIBP 3226 trifluoroacetate is a non-peptide antagonist used to study NPY Y1 and NPFF receptor signaling. Its nanomolar binding profile and reported inhibition of NPFF-regulated cAMP responses support applications in NPY/NPFF system research, anxiety research, analgesia mechanism study, and cardiovascular regulation research.

• Bay 11-7821: NF-κB Research Guide

  2026-08-17

  Bay 11-7821, also known as BAY 11-7082, is a research IKK inhibitor for mechanistic studies of NF-κB signaling, inflammation, and apoptosis. Product and literature evidence support pathway inhibition and cancer-model applications, but they do not establish clinical efficacy or a direct role in lactate-driven sepsis biology.

• KG-501: CREB–KIX Inhibition for Cancer Research

  2026-08-17

  KG-501 is a small-molecule inhibitor of CREB-mediated transcription that disrupts CREB–CBP KIX recruitment. The compound, also called 3-((4-chlorophenyl)carbamoyl)naphthalen-2-yl dihydrogen phosphate, provides a cell-based tool for studying transcriptional coactivator disruption, Myb signaling, and cancer-associated gene regulation.

• Nuclear cGAS, CHK2, and L1 Retrotransposition

  2026-08-16

  The reference study shows that nuclear cGAS protects genome integrity by recruiting TRIM41 to ubiquitinate and degrade the LINE-1 protein ORF2p. It further connects DNA damage signaling to this pathway through CHK2-dependent phosphorylation of cGAS, providing a mechanistic framework for studying retrotransposition in senescence, aging, and tumorigenesis.

• Protein A/G Magnetic Co-IP/IP Kit for BATF2-ATF3

  2026-08-15

  Use the Protein A/G Magnetic Co-IP/IP Kit to convert mechanistic questions about BATF2-ATF3 signaling into controlled interaction-capture experiments. Its recombinant Protein A/G magnetic beads support rapid co-immunoprecipitation, western blot validation, mass spectrometry, and antibody purification from mammalian samples.

• BML-277: Applied Chk2 Inhibitor Workflows

  2026-08-14

  BML-277 connects nanomolar biochemical checkpoint inhibition with practical cellular studies of DNA damage, T-cell survival, and genome stability. This workflow-focused guide explains dosing logic, assay controls, translational applications, and troubleshooting without equating biochemical potency with cellular response.

• Vitamin C Workflows for Organoid and Cancer Research

  2026-08-14

  Use Vitamin C (ascorbic acid) as a controlled perturbation in CT26 cancer assays and as an exploratory variable in physiologically relevant HEV organoids. This workflow separates established dose-response evidence from hypothesis-generating antiviral experiments, with practical guidance for fresh-solution handling, controls, and interpretation.

• Protein A/G Magnetic Co-IP/IP Kit: Ubiquitin Studies

  2026-08-13

  Discover how the Protein A/G Magnetic Co-IP/IP Kit can clarify regulated protein associations in stem-cell differentiation research. This guide connects magnetic immunoprecipitation with the PML–HIF1AN–HIF1α pathway while distinguishing physical interaction evidence from causal mechanistic proof.

• QNZ (EVP4593) NF-κB Workflow Guide

  2026-08-13

  QNZ (EVP4593) combines nanomolar NF-κB pathway inhibition with practical applications in inflammatory signaling and Huntington’s disease research. This guide translates its reported activity into reproducible reporter, cytokine, viability, and neuronal calcium-flux workflows, with formulation and troubleshooting guidance.

• Hydroxychloroquine Sulfate: Workflow Guide

  2026-08-12

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research tool for studying autophagy pathway modulation and toll-like receptor signaling in autoimmune disease research. It is suited to short-term, water-based cell and animal-model workflows, but should not be selected for protocols requiring DMSO or ethanol solubility or long-term storage of prepared solutions.

15677 records 1/1046 page Next 12345 下5页 Last page